Evaluation of the treatment of hyperphosphatemia in hemodialysis patients with diabetes mellitus
Phase 4
- Conditions
- To compare the difference of vascular calcification between lanthanum carbonate and calcium carbonate administered group in hemodialysis patients with diabetes mellitus
- Registration Number
- JPRN-UMIN000004633
- Lead Sponsor
- ippon Kokan Fukuyama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients with poor glycemic control -Patients with severe vascular complication -Patients who meet the contraindication criteria in package insert of lanthanum carbonate or calcium carbonate -Pregnant or possibly pregnant patients, patients on lactation -Inappropriate patients for this study according to the investigator's judgement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal aortic calcification
- Secondary Outcome Measures
Name Time Method -Serum phosphate,calcium and intact-PTH -Bone metabolism markers (osteocalcin and bone alkaline phosphatase) -Bone density -Calcification evaluated by PWV,IMT and parathyroid ultrasonography -Nutritional assessment -Dose of vitamin D